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Objective: The net benefit for patients undergoing carotid endarterectomy is critically dependent on the risk of
perioperative stroke and death. Information about risk factors can aid appropriate selection of patients and inform efforts
to reduce complication rates. This study identifies the clinical, radiographic, surgical, and anesthesia variables that are
independent predictors of deaths and stroke following carotid endarterectomy.
Methods: A retrospective cohort study of patients undergoing carotid endarterectomy in 1997 and 1998 by 64 surgeons
in 6 hospitals was performed (N  1972). Detailed information on clinical, radiographic, surgical, anesthesia, and
medical management variables and deaths or strokes within 30 days of surgery were abstracted from inpatient and
outpatient records. Multivariate logistic regression models identified independent clinical characteristics and operative
techniques associated with risk-adjusted rates of combined death and nonfatal stroke as well as all strokes.
Results: Death or stroke occurred in 2.28% of patients without carotid symptoms, 2.93% of those with carotid transient
ischemic attacks, and 7.11% of those with strokes (P < .0001). Three clinical factors increased the risk-adjusted odds of
complications: stroke as the indication for surgery (odds ratio [OR], 2.84; 95% confidence interval [CI]  1.55-5.20),
presence of active coronary artery disease (OR, 3.58; 95% CI 1.53-8.36), and contralateral carotid stenosis>50% (OR,
2.32; 95% CI  1.33-4.02). Two surgical techniques reduced the risk-adjusted odds of death or stroke: use of local
anesthesia (OR, 0.30; 95% CI  0.16-0.58) and patch closure (OR, 0.43; 95% CI  0.24-0.76).
Conclusions: Information about these risk factors may help physicians weigh the risks and benefits of carotid endarter-
ectomy in individual patients. Two operative techniques (use of local anesthesia and patch closure) may lower the risk of
death or stroke. (J Vasc Surg 2005;42:420-8.)Few surgical procedures have undergone as much scru-
tiny and rigorous evaluation as carotid endarterectomy.
Following a period of early enthusiasm and then concern
about the high rates of complications, several large, ran-
domized, controlled clinical trials (RCTs) were undertaken
to assess more objectively who benefits and who does not
from the procedure.1-7 The RCTs have shown that carotid
endarterectomy plus medical therapy is superior to medical
therapy alone for preventing stroke and death in selected
patients with significant internal carotid artery stenosis.1-7
National subspecialty guidelines on carotid endarterectomy
emphasize three key factors in selecting appropriate pa-
tients for surgery: the presence of neurologic symptoms,
degree of internal carotid artery stenosis, and the perioper-
ative death or stroke rate of the surgical team.8,9
While the RCTs have diminished the amount of uncer-
tainty about who is an appropriate candidate for surgery, we
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420recently reported that 10.6% of operated cases still appear
to be selected inappropriately.10 Even in the hands of
surgeons with excellent overall results, patients with a high
comorbid illness burden, who otherwise meet national
guideline criteria for surgery, may experience perioperative
complication rates that make the short-term risks greater
than the long-term benefits of surgery.10 In order to fur-
ther improve the appropriate selection of patients, more
information is needed about the determinants of perioper-
ative risk and what, if anything, can be done to lower the
risk among those who undergo the procedure.
Although many studies have identified various individ-
ual preoperative risk factors for complications following
carotid endarterectomy, most previous investigations have
been single institution studies,11-13 did not identify multi-
variate predictors of adverse outcomes,14-16 or focused
solely on in-hospital complications.14,15,17 Those multi-
center studies that used multivariate techniques to identify
30-day outcomes, focused exclusively on Medicare benefi-
ciaries18,19 or the highly selected patients and surgeons
who participated in the RCTs.20-24 The multicenter studies
of real-world practice that have sought to identify multivar-
iate predictors of stroke and death within 30 days of surgery
have identified a somewhat conflicting list of neurologic,
cardiac, and process of care variables.18,25-27
The benefits of employing various operative techniques
when performing carotid endarterectomy (such as type of
anesthesia, patching, shunting, and eversion) are contro-
versial. Few, if any, adequately powered RCTs have evalu-
ated these techniques. Because a large RCT of different
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challenging undertaking, careful examination of high-
quality, clinically risk-adjusted observational data may pro-
vide important insights about their relative effectiveness.
Only a few multi-institutional observational cohort
studies have attempted to examine which specific surgical
and perioperative management techniques are associated
with risk-adjusted outcomes, variables that represent po-
tentially modifiable risk factors.17,18,20,22,24 These studies
have yielded mixed findings, and their generalizability to
the overall population of patients and surgeons is limited
partly by their focus on Medicare beneficiaries,18 patients
and surgeons who participated in the RCTs20,22,24 or a
voluntary registry.17
The aims of this study were to use data from a large
multicenter observational cohort study to (1) identify the
preoperative patient risk factors that are significant inde-
pendent predictors of death or nonfatal stroke within 30
days of carotid endarterectomy and (2) determine whether
certain surgical, anesthesia, and medical management tech-
niques are associated with complication rates after adjusting
for key patient risk factors.
METHODS
Study population. We identified all patients who un-
derwent carotid endarterectomy (ICD-9 CM 38.12) be-
tween January 1, 1997 and December 31, 1998 in six
hospitals using administrative databases as described previ-
ously.10 Four hospitals were university teaching hospitals
and two were community teaching hospitals. The study was
approved by each site’s institutional review board. Because
two high-volume surgeons each had performed more than
250 procedures, we randomly sampled 50% of the cases of
these two very high volume surgeons and 100% of all other
physicians’ cases.
We reviewed the medical records of 2365 of 2390 cases
identified by administrative records (98.9%). For this re-
port, we focus on the 1972 patients who underwent a
confirmed, single carotid endarterectomy procedure. Rea-
sons for exclusion included carotid endarterectomy com-
bined with coronary artery bypass graft surgery (149), same
side reoperations (91), surgery combined with another
major procedure (47), missing data (55), or no carotid
endarterectomy performed (37). Because patients with cre-
scendo transient ischemic attacks (TIAs) and stroke-in-
evolution form a small, very high risk group for whom
surgery may be a last resort, these acute cases were excluded
from the risk factor analyses (n  14). Each hospital con-
tributed between 130 and 583 cases.
Data collection and measurement. Trained research
nurses abstracted detailed clinical information from inpa-
tient and outpatient medical records including sociodemo-
graphic characteristics; neurologic, medical, and surgical
history; Charlson comorbidity score28; Revised Cardiac
Risk Index29; laboratory values; medications; and diagnos-
tic test results. Severe neurologic disability was defined as
being bedridden or unable to walk/attend to own bodily
needs without assistance (equivalent to a modified Rankinscore of 4 or 5) based information in the admission history,
neurologic examination, and nursing intake assessment.
The indication for surgery was based on the acuity of the
presenting neurologic symptoms in the 12 months before
surgery according to the following hierarchy (stroke-in-
evolution, crescendo TIA, stroke, carotid TIA, vertebro-
basilar TIA, and asymptomatic) as outlined by our national
expert panel.10
Patients with unstable angina or Canadian Cardiovas-
cular Society grading scale class III or IV angina (chest pain
with ordinary or minimal activity)30 in the past 12 months
had similar risk of complications and were combined into a
subgroup called active coronary artery disease, unless they
had been successfully revascularized since that event. Ca-
rotid angiography was considered to be the most accurate
test (used in 12.1% of cases), followed by Doppler ultra-
sonography (69.6% of cases), and then magnetic resonance
angiography (11.7% of cases). If no diagnostic imaging test
data were available, we used the degree of stenosis de-
scribed in the preoperative physician notes (11.7% of cases).
Surgical specialty was determined from state licensing
board medical specialty databases as well as data from the
participating hospital.
Outcomes. We collected data on death and stroke
within 30 days of surgery from the inpatient record and
surgeon’s postdischarge office records. We reviewed office
records for 97% of surgeons and 96% of cases. We also
reviewed all readmissions to the index hospital within 30
days of surgery to identify complications. The vast majority
of deaths and strokes within 30 days of carotid endarterec-
tomy occur early and during the index hospitalization.22
Two physician investigators (one a neurologist [S.T.]) in-
dependently reviewed the medical records of all patients
who sustained confirmed or possible strokes (including
perioperative TIAs) as complications of their surgery. Ini-
tial agreement was 95%. Disagreements were resolved by
consensus and the use of a third physician reviewer.
Analysis plan. We examined predictors of two main
outcome variables: (1) a combined end point of death or
nonfatal stroke within 30 days of surgery and (2) all strokes
within 30 days of surgery (fatal and nonfatal). The relation-
ship between the two major outcomes and each risk factor
(sociodemographics, clinical characteristics, indications for
surgery, radiographic results, and surgical, anesthesia, and
medical management techniques) was examined with 2
tests and Cochrane-Mantel-Haenzel tests for trend for
categorical variables and t tests andWilcoxon rank sum tests
for continuous data, as appropriate.
Linear and quadratic functions of age were tested in the
models, and these functions were compared with categor-
ical variables (age intervals) to find the best functional form.
For categorical variables with more than two groups, cate-
gories with similar adverse outcome rates were combined.
The type of surgical closure was categorized as primary
closure, patch graft, or eversion. For the analyses of closure
type, we excluded six cases of interposition grafts. We
determined which risk factors on admission were associated
with adverse outcomes using the univariate tests above. All
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at the P  .2 level were entered in a multivariable, logistic
regression model. All those predictors significant at the P
.05 level were retained in a final patient risk factor model.
We added the process of care variables significant at the P
.2 level to the final patient risk factor model to determine
which perioperative techniques influenced risk-adjusted
outcomes. We used generalized estimating equations to
account for the clustering of observations (ie, patients by
surgeon and surgeons within hospitals). Alternate models
that forced into the final regression model comorbid illness
burden or caseload volume produced similar results. All
analyses consider two-sided P values of .05 as statistically
significant and were performed using SAS 8.2 (SAS Insti-
tute, Cary NC).
RESULTS
The characteristics of patients on admission for the
1972 cases that we examined are presented in Table I. The
average patient was 72.4  8.6 years old with 1.8  1.5
comorbid conditions. The clinical indications for surgery
were asymptomatic carotid stenosis in 69.9%, vertebrobasi-
lar TIA in 1.4%, carotid TIA in 17.3%, and stroke in 11.4%.
Among the 14 excluded cases for crescendo TIA and
stroke-in-evolution, the combined rates of death or stroke
were 28.57% and 57.14%, respectively. Among those with a
surgical indication of stroke, 9.0% had a major stroke and
91.0% had a minor stroke. Overall, 71.3% of patients un-
derwent carotid endarterectomy in the absence of symp-
toms or had symptoms in a vascular territory other than that
of the operated artery (vertebrobasilar TIA). Most patients
had a 70%-99% ipsilateral stenosis (89.8%). The degree of
contralateral carotid stenosis varied widely.
The carotid endarterectomies were performed by 64
surgeons (vascular, n  38; neurosurgical, n  10; cardio-
thoracic, n  8; and general, n  8). Vascular surgeons
performed 67.0% of the procedures, general surgeons,
21.2%; cardiothoracic surgeons, 7.6%; and neurosurgeons,
4.2%. The median length of stay was 2 days.
Outcomes. There were 12 deaths and 52 strokes (46
nonfatal strokes) within 30 days of surgery, for a combined
rate of death or nonfatal stroke of 2.95%. Of the 12 deaths,
three were due to perioperative stroke, two due to myocar-
dial infarction, three occurred in patients with both a
perioperative stroke and a myocardial infarction, and four
due to other causes.
Univariate associations between clinical, hospital,
and surgeon characteristics and outcomes. Table I dis-
plays the various risk factors on admission and their associ-
ations with adverse outcomes. Overall, rates of combined
death and stroke were higher among symptomatic patients
(carotid TIA and stroke) compared to those without ca-
rotid symptoms (4.59% vs 2.28%; odds ratio [OR], 2.06;
95% confidence interval [CI] 1.22-3.49; P .006). This
was primarily due to a higher risk of any stroke among
symptomatic patients (4.06% vs 2.07%, OR, 2.00; 95% CI
 1.15-3.49, P  .0001). Asymptomatic patients hadsimilar rates of combined death/stroke compared to those
with carotid TIAs (2.28% vs 2.93%, P .48) and any stroke
(2.07% vs 2.63%, P  .51). Patients with stroke as the
indication for surgery had the highest rate of death or
stroke (7.11%). Among symptomatic patients, the recency
of stroke or TIA within 12 months did not influence
outcomes.
Other factors associated with significantly higher risk of
complications include admission source, Revised Cardiac
Risk Index, Charlson comorbidity score, active coronary
artery disease, congestive heart failure, cerebrovascular dis-
ease, degree of ipsilateral stenosis, functional limitations,
and severe neurologic disability. There appeared to be a
U-shaped relationship between the degree of ipsilateral
stenosis and complications in which the risk of death or
stroke was higher for complete occlusion and minimal
stenosis. Operating on a 30% stenosis quadrupled the
odds of combined death and stroke (11.11% vs 2.84%, P
.01; OR, 4.28, 95% CI  1.25-14.65; P  .01). The
absolute degree of contralateral stenosis was of borderline
significance, although contralateral stenosis 50% was sig-
nificantly associated with twice the odds of death and stroke
(4.30% vs 1.90%, P  .002; OR, 2.32, 95% CI  1.35-
4.00). Age, sex, race, and artery side did not appear to
influence rates of death or stroke.
There were no statistically significant differences by
hospital in term of rates of combined death/stroke (range,
2.08%-3.63%, P  .22) or stroke alone (range, 1.61%-
3.63%, P .17). There were individual surgeon differences
in rates of combined death/stroke (range, 0%-100%, P 
.0001) and stroke alone (range, 0%-100%, P  .0001),
although this was largely due to a few extreme high values
due to surgeons with fewer than five cases in the sample.
When we excluded surgeons who had five or fewer cases,
there were no longer any statistically significant differences
by individual surgeon (range, 0%-12.5% for both death/
stroke and stroke alone, P .21 and P .17, respectively).
There were significant differences in unadjusted rates of
combined death or stroke by surgeon specialty (vascular
surgery, 2.93%; general surgery, 1.88%; cardiothoracic sur-
gery, 3.33%; neurosurgery, 8.64%; P  .05) as well as
stroke alone (vascular, 2.54%; general, 1.67%; neurosur-
gery, 8.64%; and cardiothoracic, 3.33%; P  .004). This
was largely due to differences in patient case mix as the
multiple logistic regression analyses below reveal.
Multivariate associations between patient charac-
teristics and outcomes. The clinical characteristics that
were independently related to rates of combined death or
stroke or stroke alone are shown in Table II. Stroke as the
indication for surgery tripled the odds of death and stroke
(OR, 3.06; 95% CI  1.68-5.58) and stroke alone (OR,
2.96; 95% CI  1.57-5.60). Active coronary artery disease
tripled the odds of death and stroke (OR, 3.59; 95% CI 
1.56-8.27) and stroke alone (OR, 4.07; 95% CI  1.76-
9.44). Contralateral stenosis 50% also doubled the odds
of death/stroke (OR, 2.22; 95% CI  1.28-3.83) and
stroke alone (OR, 2.18; 95% CI  1.22-3.88).
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Prevalence
(%)
Death/stroke
rate (%) P Stroke rate (%) P
Sex
Male 56.9 2.77 .58 2.41 .46
Female 43.1 3.19 2.95
Age (y)
60 7.9 4.49 .48 4.49 .64
60-69 25.8 2.56 2.56
70-79 45.3 3.03 2.58
80 21.0 2.66 2.18
Race/ethnicity
White 88.1 3.00 .93 2.71 .84
Black 2.5 4.00 4.00
Hispanic 2.1 2.44 2.44
Other/unknown 7.3 2.10 1.39
Admitted from ED
Yes 7.0 5.84 .04 4.38 .19
No 93.0 2.73 2.51
Admit source
Home 97.2 2.98 .63 4.38 .71
Transfer 2.8 1.85 2.51
Ipsilateral stenosis
Occluded 1.5 6.67 .13 3.33 .66
70-99% 89.8 2.72 2.49
60-69% 3.8 4.00 4.00
50-59% 1.4 3.70 3.70
30-49% 2.1 2.44 2.44
0-29% 1.4 11.11 7.41
Contralateral stenosis
Occluded 6.2 4.96 4.96
70-99% 26.1 3.90 3.31
60-69% 6.2 4.88 .055 4.88 .06
50-59% 5.2 4.85 3.88
30-49% 20.3 2.25 2.00
0-29% 35.9 1.70 1.56
Ulcerated plaque
None 94.0 2.87 .69 2.39 .54
Shallow 4.8 4.26 4.26
Deep 1.2 4.17 4.17
Operated artery
Left 49.6 2.56 0.31 2.25 .28
Right 50.4 3.33 3.03
Neurologic indication
Asymptomatic 69.9 2.40 .0001 2.07 .001
Vertebrobasilar TIA 1.4 0.00 0.00
Carotid TIA 17.3 2.93 2.64
Stroke 11.4 7.11 6.22
Severe neurologic disability
Yes 2.1 7.32 .09 4.88 .36
No 97.9 2.86 2.60
Revised Cardiac Risk Index
0 19.6 1.30 1.04
1 46.1 2.65 .003 2.43 .02
2 25.5 3.39 3.39
3 8.7 6.98 5.23
Charlson comorbidity score
0 17.7 1.76 1.76
1 32.0 1.95 1.79
2 23.0 2.95 .02 2.71 .07
3 27.3 4.57 4.00
Coronary artery disease
Yes 57.4 3.17 .34 2.90 .34
No 42.6 2.44 2.20
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outcomes. We examined variations in 18 surgical, anes-
thetic, and medical management techniques and their im-
pact on outcomes (Table III). Procedures performed under
local anesthesia had less than half the odds of death or
stroke (1.56% vs 3.65%, OR, 0.42; CI  0.22-0.79; P 
.005). Patients who had an arterial shunt placed had higher
rates of adverse events (4.75% vs 1.82%; OR, 2.69; 95% CI
 1.57-4.61), although this may have been because shunt-
ing was performed in higher risk patients (see final multi-
variate results section below). Closure of the arteriotomy
with a patch graft (either synthetic material or vein) or
eversion was associated with lower death or stroke rates
compared to primary closure (2.54% vs 2.48% vs. 6.22%,
P  .009). The effects of local anesthesia, shunting, and
closure type on rates of stroke alone were nearly identical to
those for the combined end point of death and stroke.
None of the other surgical techniques appeared to influ-
Table I. Continued.
Prevalence
(%)
Deat
ra
Active coronary disease
Yes 4.2 8
No 95.8 2
Valvular disease
Yes 8.8 3
No 91.2 2
Hypertension
Yes 72.7 2
No 27.3 2
Congestive heart failure
Yes 6.8 6
No 93.2 2
Peripheral vascular disease
Yes 28.3 3
No 71.7 2
Renal insufficiency
Yes 4.0 3
No 96.0 2
Cerebrovascular disease*
Yes 45.4 3
No 54.6 1
Diabetes mellitus
Yes 28.0 3
No 72.0 2
Diabetes on insulin
Yes 7.3 4
No 92.7 2
Pulmonary disease
Yes 12.9 3
No 87.1 2
Current smoking
Yes 14.1 2
No 85.9 3
Alcohol use
Yes 9.6 2
No 90.4 2
ED, emergency department; TIA, transient ischemic attack.
*History of transient ischemic attack or stroke ever.ence outcomes.Overall multivariate associations with outcomes.
Multiple logistic regression models of all the clinical, radio-
graphic, surgical, anesthetic, and medical management
variables examined in Tables I, II, and III revealed five
independent risk factors for perioperative death or stroke
(Table IV). Three clinical factors on admission were inde-
pendently associated with double to triple the risk-adjusted
odds of combined death or stroke and stroke alone: stroke
as the indication for surgery, active coronary artery disease,
and contralateral stenosis 50%. Two perioperative man-
agement techniques, using local anesthesia and using a
patch graft, were associated with reducing the risk-adjusted
odds of combined death or stroke and stroke alone by
between 57% and 70%. Similar results were obtained in
alternative logistic regression models that retained the
other nonsignificant candidate predictor variables. After
adjusting for the other risk factors outlined in Table IV,
there were no differences in rates of combined death or
oke
P Stroke rate (%) P
.002 8.54 .0007
2.39
.67 3.47 .48
2.57
.96 2.66 .95
2.61
.02 4.58 .13
2.45
.64 2.51 .82
2.70
.58 2.60 .99
2.60
.01 3.58 .01
1.80
.26 3.63 .09
2.26
.30 4.26 .20
2.47
.34 3.55 .34
2.51
.65 2.53 .89
2.66
.79 2.12 .63
2.70h/str
te (%)
.54
.71
.47
.90
.94
.99
.11
.62
.23
.84
.90
.84
.92
.99
.63
.68
.26
.75
.55
.86
.53
.02
.65
.98stroke or stroke alone by surgical specialty.
mbin
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In this study of 1972 patients undergoing carotid end-
arterectomy by 64 different surgeons at six hospitals during
1997 and 1998, the overall 30-day rate of death or nonfatal
stroke was 2.95%. The complication rate among symptom-
atic patients was twice that of those without carotid symp-
toms (4.59% vs 2.28%; P  .0006). With direct access to
detailed clinical data in the inpatient and outpatient medi-
cal records, we were able to assess the prognostic signifi-
cance of more than 25 different, clinical, radiographic,
surgical, anesthesia, and medical management risk factors
for death or stroke following carotid surgery. Our multiple
regression results identified three independent clinical fac-
tors that doubled to tripled the risk-adjusted odds of ad-
verse outcomes: stroke as the indication for surgery, pres-
ence of active coronary artery disease, and contralateral
stenosis 50%. Two surgical techniques reduced the risk-
adjusted odds of complications: use of local anesthesia and
use of patch angioplasty.
The traditional approach to evaluating the appropriate-
ness of carotid endarterectomy emphasizes whether the
patient is symptomatic or asymptomatic and has signif-
icant ipsilateral carotid stenosis. Our results confirm and
extend the findings of others that it is also important to
further distinguish symptomatic patients according to the
underlying neurologic indication for surgery (TIA vs
stroke).21,22,27,31 Although fewer previous studies have
used multiple regression analysis to identify independent
risk factors for perioperative death or stroke, those that
have reported conflicting conclusions about whether com-
plication rates are different for patients with stroke vs
carotid TIAs. One meta-analysis found an overall trend in
this direction,31 whereas an older one did not.32 Bond
et al31 also found that patients undergoing carotid end-
arterectomy for evolving symptoms had higher compli-
cation rates.
The most important cardiac risk factor for complica-
tions was active coronary artery disease (unstable angina or
angina with ordinary or minimal activity in the past 12
months). This is a new finding as previous studies have only
examined the presence (or absence) of angina, not its
severity.14,15,21,33 This finding is particularly noteworthy
because we excluded from our analyses patients who were
undergoing simultaneous carotid endarterectomy and cor-
Table II. Multivariate associations between patient charac
Death and
OR 95% CI
Stroke as indication for surgery 3.06 1.68-5.5
Active CAD 3.59 1.56-8.2
Contralateral stenosis 50% 2.22 1.28-3.8
OR, odds ratios; CI, confidence interval; CAD, coronary artery disease.
Stroke alone includes fatal and nonfatal strokes.
*Death and stroke indicates the 30-day rate of death and nonfatal stroke coonary artery bypass graft surgery. This suggests that pa-tients with recent unstable angina or angina with usual
activities may be too high risk to benefit from carotid
surgery or may require revascularization before surgery.
Although many previous studies reported a higher risk
of complications in patients with contralateral occlusion
(compared to those with a patent artery),13,27,32,34 few
investigators evaluated the impact of subtotal occlusion.
Complete contralateral occlusion is uncommon. However,
more than one third of patients in our sample had contralat-
eral stenosis between 50% and 99%, and they experienced
similarly higher rates of complications rates as those who
had complete occlusions perhaps reflecting limitations in
collateral blood flow reserve. Among other studies that
examined subtotal occlusion, some reported higher rates
of complications,17,22,26 whereas others did not.15,21,35
Given this discordance in the literature, this finding will
need to be confirmed in other studies.
Lower risk-adjusted rates of complications for cases
under local anesthesia have been reported in many, but not
all, previous reports, although this was not a protective
factor in the North American Symptomatic Carotid Endar-
terectomy Trial (NASCET) and European Carotid Surgery
Trial (ECST).20,22,36,37 Although the distribution of cases
that used local anesthesia in this study did vary by hospital
(0%, 1%, 1%, 6%, 42%, and 50% of cases, P .0001) and by
surgeon (P .0001), this was not just an individual hospi-
tal or surgeon effect. Overall, 26 surgeons (41%) did at least
some of their cases under local anesthesia. We believe that
the association between local anesthesia and lower compli-
cation rates in this data set is robust for several reasons.
First, the models included several major covariates that are
strong predictors of death and stroke. Second, the finding
applied to both the outcome of all strokes as well as
combined death and nonfatal stroke, so this result was not
just driven by a lower immediate risk of death under local
anesthesia. Third, from a statistical standpoint, the risk-
adjustment model (with a c statistic of 0.74) did a good job
of explaining the variation in death and stroke rates.
Fourth, alternate models that forced in other potential
confounders such as other comorbid illness burden or
caseload volume produced similar results.
The use of a patch to close the arteriotomy site (com-
pared to primary closure) was also associated with signifi-
cantly lower risk-adjusted complication rates in our study.
tics and complication rates*
Stroke alone
P OR 95% CI P
.0003 2.96 1.57-5.60 .0008
.003 4.07 1.76-9.44 .001
.004 2.18 1.22-3.88 .008
ed.teris
stroke
8
7
3Systematic reviews of the small RCTs of patching found
irin, c
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arterial occlusion and restenosis, although there were not
adequate data to assess its influence on death or stroke
rates.38,39 The use of patch angioplasty in observational stud-
ies has shownmixed results in several large studies with better
outcomes in one,18 borderline significance in another,15 but
no benefit in several others.17,20,22
The fact that one in five patients did not appear to be
discharged on antiplatelet or anticoagulant therapy was
concerning.We suspect that this is an overestimate andmay
Table III. Prevalence of key operative processes of care an
Prevalence
(%)
Anesthesia
Local 42.6
General 56.0
Both 1.5
Lidocaine injection of carotid
Yes 11.1
No 88.9
Shunt
Yes 38.5
No 61.5
Type of internal carotid artery closure
Patch closure 70.1
Eversion 18.5
Primary closure 11.4
Eversion of external carotid
Yes 51.1
No 48.9
Tacking sutures
Yes 16.7
No 83.3
Plaque trimmed
Yes 16.2
No 83.8
Plication
Yes 20.6
No 79.4
Intraoperative Doppler probe
Yes 11.9
No 88.1
Intraoperative heparin
Yes 98.3
No 1.7
Protamine reversal
Yes 47.5
No 52.5
APAC* just before surgery
Yes 6.1
No 93.9
APAC* after surgery
Yes 67.5
No 32.5
APAC* on discharge
Yes 79.5
No 20.5
Lipid medications on discharge
Yes 30.0
No 70.0
APAC, antiplatelet/anticoagulant.
*Antiplatelet or anticoagulant medications (APAC) included use of any aspbe partly an artifact for how variably discharge medications(especially over-the-counter medicines like aspirin) are doc-
umented in the medical record. However, given the evi-
dence that these medications reduce of stroke after carotid
endarterectomy, any significant underuse among patients
undergoing a procedure to prevent stroke is a major quality
problem.18,40
Several strengths and limitations of the current study
are worth noting. First, we examined a large number of
cases, of all ages and comorbid illness burden, being oper-
ated on by 64 surgeons in six hospitals. Second, by review-
sociated mortality/stroke rates
th/stroke
te (%) P Stroke rate (%) P
1.56 1.56
3.65 .0001 3.10 .001
7.24 17.24
2.74 .85 2.74 .92
2.97 2.63
4.75 .0002 4.22 .0006
1.82 1.65
2.54 .009 2.18 .007
2.48 2.48
6.22 5.78
2.89 .86 2.39 .47
3.01 2.91
2.74 .80 2.13 .52
2.99 2.75
3.45 .56 2.82 .83
2.85 2.61
2.22 .33 1.98 .35
3.14 2.82
4.27 .20 3.85 .22
2.77 2.48
3.00 .31 2.69 .34
0.00 0.00
3.10 .70 2.67 .94
2.81 2.62
4.17 .42 4.17 .28
2.87 2.54
2.66 .60 2.79 .57
3.09 2.35
2.66 .007 2.30 .06
3.09 3.97
3.27 .20 2.30 .27
2.20 2.90
lopidogrel, ticlopidine, dipyridamole, or warfarin.d as
Dea
ra
1ing subsequent readmissions and outpatient records, we
mbin
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perioperative period that occurred after the index hospital-
ization. Most previous studies of real-world practice have
only reported in-hospital event rates. Only the prospective
RCTs have reported 30-day death or stroke rates. How-
ever, the RCTs excluded patients who were older or had
significant comorbidities, subgroups that represent a con-
siderable proportion of those undergoing the procedure in
real-world practice.
Third, we collected highly detailed clinical information
on more than 30 different clinical, radiographic, surgical,
anesthesia, and medical management variables with which
to perform multivariate regression and identify predictors
of risk-adjusted outcomes. Fourth, we present a risk-
adjustment model for all patients undergoing carotid end-
arterectomy, not just those with symptoms. Asymptomatic
patients now account for about three fourths of the patients
undergoing the procedure in the United States, and few (if
any) surgeons or hospitals operate on just symptomatic or
asymptomatic patients.10,18 Future population-based stud-
ies of the outcomes of carotid endarterectomy will require
risk-adjustment models that include all cases, not just those
with or without neurologic symptoms.
The six participating hospitals were all medium- or
high-volume hospitals with respect to carotid endarterec-
tomy and had teaching programs (university and commu-
nity), so the extent to which our findings can be extrapo-
lated to other settings is unclear. Our lack of risk-adjusted
volume or surgeon specialty effects may be also be due to
the lack of sufficient variation on these characteristics
and/or adequate statistical power to ascertain modest ef-
fects of these factors in this sample. The proportion of
vascular surgeons in the sample was also larger than the
statewide average. However, the 30-day death or stroke
rate of 4.59% among symptomatic patients was comparable
to the overall rate of 5.1% reported in a recent meta-analysis
of 95 studies of symptomatic patients.31 These complica-
tion rates are also similar (or somewhat lower) than those
reported in the highly selective NASCET and ECST, which
reported rates of 6.5% and 7.1%.21,22 The death or stroke
rate of 2.28% among asymptomatic patients in our study
was slightly lower than the global risk of 2.8% from a recent
meta-analysis of 60 studies of asymptomatic patients the
Table IV. Final multiple logistic regression model of com
Death and
OR 95% CI
Stroke as indication for surgery 2.84 1.55-5.2
Active CAD 3.58 1.53-8.3
Contralateral stenosis 50% 2.32 1.33-4.0
Local anesthesia 0.30 0.16-0.5
Patch closure 0.43 0.24-0.7
OR, odds ratios; CI, confidence interval; CAD, coronary artery disease.
Stroke alone includes fatal and nonfatal strokes.
*Death and stroke indicates the 30-day rate of death and nonfatal stroke coliterature31 and nearly identical to the 2.3% and 3.1%perioperative event rates found in the two main asymptom-
atic trials.3,7 Taken together, this suggests that the sur-
geons and hospitals we examined appear comparable to the
larger population of those performing carotid endarterec-
tomy included in published studies. Even with our large
sample size, the numbers of deaths and nonfatal stroke were
low, limiting our ability to detect weak associations.
Finally, the two surgical techniques that we found to be
associated with lower risk-adjusted complication rates (local
anesthesia andpatch angioplasty)were selected as part of usual
care, not by a process of randomization, so we are cau-
tious about inferring causation. However, these hypothesis-
generating results in combination with other those of other
studies are provocative and provide a growing rationale for
further serious research in this area. Two strategies could
help to more definitively answer this question. The gold
standard approach would involve a large RCT evaluating
the efficacy of these operative techniques, although this
may be very difficult to do for a variety of reasons. An
alternative approach would be to selectively supplement
state or national administrative databases with clinical data
regarding key processes of care and clinical characteristics
that would permit high-quality, risk-adjusted estimates of
the effect of these techniques on outcomes.
In summary, we identified five independent predictors
of risk-adjusted rates of death or stroke following carotid
endarterectomy. This risk model may be useful in helping
surgeons and referral physicians to weigh which patients
might benefit from surgery as well as identify patients at
high risk who may benefit from more aggressive perioper-
ative management and monitoring. It may also help inform
future research or quality improvement efforts that seek to
measure and ultimately reduce risk-adjusted complication
rates following carotid endarterectomy. This information
may also be useful to surgical training programs in high-
lighting two techniques that all surgeons performing ca-
rotid endarterectomy should have in their armamentarium.
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tion rates*
Stroke alone
P OR 95% CI P
.0008 2.78 1.46-5.28 .002
.003 4.00 1.70-9.37 .002
.003 2.28 2.28-4.08 .005
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stroke
0
6
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